Astellas Signs Strategic Oncology Partnership With Ambit After Medivation Success

The deal is the third oncology partnership agreement signed by Astellas with a U.S. biotech in as many months..

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet